The Technical Analyst
PROCEPT BioRobotics [PRCT]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
PROCEPT BioRobotics Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-2.36% $52.48
America/New_York / 24 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 674.60 mill |
| EPS: | -2.24 |
| P/E: | -23.43 |
| Earnings Date: | May 01, 2024 |
| SharesOutstanding: | 50.96 mill |
| Avg Daily Volume: | 0.480 mill |
| RATING 2024-04-24 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -23.43 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.11x |
| Company: PE -23.43 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 50.40 - 54.56 ( +/- 3.97%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-18 | Wood Larry L | Buy | 5 284 | Stock Option (Right to Buy) |
| 2024-04-18 | Wood Larry L | Buy | 3 054 | Common Stock |
| 2024-03-06 | Zadno Reza | Buy | 48 575 | Common Stock |
| 2024-03-06 | Zadno Reza | Buy | 42 311 | Stock Option (Right to Buy) |
| 2024-03-06 | Waters Kevin | Buy | 13 275 | Common Stock |
| INSIDER POWER |
|---|
| 2.96 |
| Last 100 transactions |
| Buy: 687 056 | Sell: 915 626 |
Forecast:
16:00 - $52.48
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $52.48
Forecast 2: 16:00 - $52.48
Forecast 3: 16:00 - $52.48
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $52.48 (-2.36% ) |
| Volume | 0.512 mill |
| Avg. Vol. | 0.480 mill |
| % of Avg. Vol | 106.74 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PRCT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $48.99 | N/A | Active |
|---|
PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Last 10 Buy Signals
Latest Press Releases
2024-04-23 08:00:00 - Press Release
Procept Biorobotics Announces 12 Scientific Research Presentations On Aquablation Therapy For The Treatment Of Benign Prostatic Hyperplasia At The 2024 Aua Annual Meeting
Presentations include first published experience report of same-day discharge in an ambulatory surgical center, real-world data outcomes and 5-year data comparison between two fda trials presentations include first published experience report of same-day discharge in an ambulatory surgical center, real-world data outcomes and 5-year data comparison between two fda trials
2024-04-04 16:04:00 - Press Release
Procept Biorobotics Corp. Announces Investor Event At 2024 Aua Annual Meeting In San Antonio, Texas
San jose, calif., april 04, 2024 (globe newswire) -- procept biorobotics® corporation (nasdaq: prct), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will host an in-person investor event on friday, may 3, 2024, at the grand hyatt hotel in san antonio, tx at the american urological association annual meeting from 8:00am to 9:30am central time.
2024-04-02 16:03:00 - Press Release
Procept Biorobotics To Report First Quarter 2024 Financial Results On May 1, 2024 And Attend The 2024 Bank Of America Healthcare Conference On May 15, 2024
San jose, calif., april 02, 2024 (globe newswire) -- procept biorobotics® corporation (the “company”) (nasdaq: prct), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the first quarter of 2024 after market close on wednesday, may 1, 2024. the company's management will host a corresponding conference call beginning at 8:00 a.m. eastern time.
2024-02-27 16:02:00 - Press Release
Procept Biorobotics Reports Fourth Quarter And Full Year 2023 Results
San jose, calif., feb. 27, 2024 (globe newswire) -- procept biorobotics® corporation (nasdaq: prct) (the “company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the year ended december 31, 2023.
2024-02-12 16:05:00 - Press Release
Procept Biorobotics To Present At The 44th Annual Td Cowen Health Care Conference In Boston
San jose, calif., feb. 12, 2024 (globe newswire) -- procept biorobotics® (nasdaq: prct) (the “company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 44th annual td cowen health care conference in boston. management is scheduled to present on tuesday, march 5 at 12:50 p.m. eastern time. a live webcast of the event, as well as an archived recording, will be available on the “investors” section of the company's website at: https://ir.procept-biorobotics.com. the webcasts will be archived and available for replay for at least 90 days after the event.
Latest News
2024-04-02 16:03:00 - GlobeNewsWire
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
SAN JOSE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the first quarter of 2024 after market close on Wednesday, May 1, 2024. The Company's management will host a corresponding conference call beginning at 8:00 a.m. Eastern Time.
2024-02-28 00:09:03 - Seeking Alpha
PROCEPT BioRobotics Corporation (PRCT) Q4 2023 Earnings Call Transcript
2024-02-13 08:51:04 - Zacks Investment Research
3 Medtech Stocks Likely to Top Estimates This Earnings Season
Here are three stocks, GMED, GKOS and PRCT, which are expected to beat earnings estimates in the ongoing reporting cycle.
2024-02-12 16:05:00 - GlobeNewsWire
PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
SAN JOSE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 44th Annual TD Cowen Health Care Conference in Boston. Management is scheduled to present on Tuesday, March 5 at 12:50 p.m. Eastern Time. A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the company's website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.
2024-01-10 05:16:03 - Zacks Investment Research
Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength?
PROCEPT BioRobotics Corporation (PRCT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
2023-11-06 11:17:45 - Zacks Investment Research
Wall Street Analysts Predict a 25.54% Upside in PROCEPT BioRobotics Corporation (PRCT): Here's What You Should Know
The mean of analysts' price targets for PROCEPT BioRobotics Corporation (PRCT) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
2023-11-02 00:01:06 - Seeking Alpha
PROCEPT BioRobotics Corporation (PRCT) Q3 2023 Earnings Call Transcript
2023-10-22 13:37:52 - InvestorPlace
The 7 Best Tech Stocks To Buy Now: October 2023
With the innovation sector moving at full speed, it's time for investors to consider the best tech stocks to buy now but not necessarily for the reason you might assume. Yes, the exchange-traded fund Technology Select Sector SPDR Fund (NYSEARCA: XLK ) has easily outperformed the benchmark SPDR S&P 500 ETF Trust (NYSEARCA: SPY ) over the past five years, 159% to 68%.
2023-10-16 16:05:00 - GlobeNewsWire
PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2023 after market close on Wednesday, November 1, 2023. The Company's management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
2023-08-17 16:05:00 - GlobeNewsWire
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2023 Wells Fargo Healthcare Conference in Boston. Management is scheduled to present on Thursday, September 7 at 3:00 p.m. Eastern Time. A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the company's website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.